📊 NNOX Key Takeaways
Is Nano-X Imaging Ltd. (NNOX) a Good Investment?
Insufficient financial data available for fundamental analysis. With only 1 Form 4 filing in the last 90 days and no income statement, balance sheet, or cash flow metrics available, a comprehensive assessment of Nano-X's financial health, profitability, and growth trajectory cannot be performed. Additional SEC filings and current financial statements are required to evaluate investment merit.
The provided SEC dataset contains no usable financials for Nano-X, preventing assessment of profitability, liquidity, or growth quality. Maintain a neutral stance until timely filings demonstrate revenue traction, improving gross margin, and disciplined cash burn.
Why Buy Nano-X Imaging Ltd. Stock? NNOX Key Strengths
- Operates in specialized medical imaging sector (X-ray apparatus) with potential for innovation
- Listed on Nasdaq indicating meeting exchange listing standards
- Some insider activity detected suggesting ongoing management engagement
- Large addressable market for medical imaging solutions
- Recurring-use/service model potential that could yield high gross margins at scale
- Ecosystem optionality from software/AI and service layers
NNOX Stock Risks: Nano-X Imaging Ltd. Investment Risks
- Critically limited financial disclosure - no revenue, profitability, or balance sheet data available
- Unable to assess liquidity, solvency, or cash burn rates
- No verifiable operating metrics to evaluate business traction or financial stability
- Extreme data scarcity prevents meaningful fundamental analysis
- Lack of current audited financials; inability to verify revenue or cash runway
- Execution risk in scaling deployments and utilization from pilots to commercial volumes
- Potential ongoing operating losses and reliance on external financing common to pre-revenue med-tech
Key Metrics to Watch
- Latest 10-K or 10-Q filing with complete revenue and income statement data
- Cash position and burn rate relative to operating requirements
- Path to profitability and gross margin trends once commercial operations commence
- Revenue growth and gross margin progression
- Operating cash burn and cash & equivalents (runway)
Nano-X Imaging Ltd. (NNOX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
NNOX Profit Margin, ROE & Profitability Analysis
NNOX vs Market Sector: How Nano-X Imaging Ltd. Compares
How Nano-X Imaging Ltd. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Nano-X Imaging Ltd. Stock Overvalued? NNOX Valuation Analysis 2026
Based on fundamental analysis, Nano-X Imaging Ltd. has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Nano-X Imaging Ltd. Balance Sheet: NNOX Debt, Cash & Liquidity
NNOX Revenue Growth, EPS Growth & YoY Performance
NNOX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Nano-X Imaging Ltd. (CIK: 0001795251)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NNOX
What is the AI rating for NNOX?
Nano-X Imaging Ltd. (NNOX) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 22% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are NNOX's key strengths?
Claude: Operates in specialized medical imaging sector (X-ray apparatus) with potential for innovation. Listed on Nasdaq indicating meeting exchange listing standards. ChatGPT: Large addressable market for medical imaging solutions. Recurring-use/service model potential that could yield high gross margins at scale.
What are the risks of investing in NNOX?
Claude: Critically limited financial disclosure - no revenue, profitability, or balance sheet data available. Unable to assess liquidity, solvency, or cash burn rates. ChatGPT: Lack of current audited financials; inability to verify revenue or cash runway. Execution risk in scaling deployments and utilization from pilots to commercial volumes.
What is NNOX's revenue and growth?
Nano-X Imaging Ltd. reported revenue of N/A.
Does NNOX pay dividends?
Nano-X Imaging Ltd. does not currently pay dividends.
Where can I find NNOX SEC filings?
Official SEC filings for Nano-X Imaging Ltd. (CIK: 0001795251) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NNOX's EPS?
Nano-X Imaging Ltd. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NNOX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Nano-X Imaging Ltd. has a HOLD rating with 22% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is NNOX stock overvalued or undervalued?
Valuation metrics for NNOX: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NNOX stock in 2026?
Our dual AI analysis gives Nano-X Imaging Ltd. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NNOX's free cash flow?
Nano-X Imaging Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.
How does NNOX compare to other Market stocks?
Vs Default sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 1.8).